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ABSTRACT 
 
In vertebrates, the first haematopoietic stem cells (HSCs) with multi-lineage 
and long-term repopulating potential arise in the AGM (aorta–gonad–mesonephros) 
region. These HSCs are generated from a rare and transient subset of endothelial 
cells, called haemogenic endothelium (HE), through an endothelial-to-
haematopoietic transition (EHT). Here, we establish the absolute requirement of the 
transcriptional repressors Growth Factor Independence 1 and 1B (GFI1 and GFI1B) 
in this unique trans-differentiation process. We first demonstrate that Gfi1 expression 
specifically defines the rare population of HE that generates emerging HSCs. We 
further establish that in the absence of GFI1 proteins, HSCs and haematopoietic 
progenitor cells are not produced in the AGM, revealing the critical requirement for 
GFI1 proteins in intra-embryonic EHT.  Finally, we demonstrate that GFI1 proteins 
recruit the chromatin modifying protein LSD1, a member of the CoREST repressive 
complex, to epigenetically silence the endothelial program in HE and allow the 
emergence of blood cells.  
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INTRODUCTION 
The vertebrate haematopoietic system is characterised by several waves of 
blood progenitor generation1. The first two waves of blood cell emergence are 
initiated in the extra-embryonic yolk sac and generate mainly primitive erythrocytes 
then erythroid-myeloid progenitors2-5. In the next wave, the intra-embryonic AGM 
region gives rise to the first haematopoietic stem cells (HSCs) with multi-lineage and 
long-term repopulating potential in adult recipients6,7. Recent studies have provided 
evidence for the existence of a subset of endothelial cells capable of generating 
blood cells; a haemogenic endothelium8-12 (HE). Live imaging studies have revealed 
how during this process of endothelial-to-haematopoietic transition (EHT), spindle-
shaped endothelial cells lose their epithelial morphology to adopt the typical round 
shape of haematopoietic cells10,11,13-16. Consistent with the generation of HSCs from 
endothelial cells, the first progenitors with HSC activity are detected in the major 
arteries17 and cells with a HSC phenotype have been found in the intra-aortic 
haematopoietic clusters (IAHC) generated through EHT from the ventral wall of the 
dorsal aorta (vDA)13,18,19.  
The molecular mechanisms controlling EHT and the specification and 
emergence of HSCs are still poorly understood. The transcription factor RUNX1 
(AML1) is a master regulator of definitive haematopoiesis that is expressed in the 
entire continuum of blood development from HE to mature haematopoietic cells20-24.
Runx1 deletion leads to mid-gestation embryonic lethality and a complete absence of 
definitive haematopoietic cells20,22,25,26 as a result of a block in the generation of 
blood cells from HE11,15,27. More recently, the two highly homologous transcriptional 
repressors GFI1 and GFI1B were identified as downstream targets of RUNX1 and 
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important players during the initial wave of haematopoietic commitment in the yolk 
sac28.  
In this study, we investigated the molecular mechanisms controlling the 
generation of HSCs during the intra-embryonic wave of haematopoiesis in the AGM 
and demonstrate a prominent role for the transcriptional repressors GFI1 and GFI1B 
in this process. By combining mouse reporter lines and functional assays, we 
established that Gfi1 expression is initiated in a rare population of HE, present in the 
vDA during HSC emergence, whereas GFI1B expression is up-regulated in 
emerging IAHC. Loss of GFI1 proteins impaired IAHC formation, indicating the 
pivotal role of these repressors during the emergence of haematopoietic cells within 
the AGM. Furthermore, we established that the critical function of the GFI1 proteins 
is mediated by the recruitment of LSD1, a member of the repressive CoREST 
complex. Deficiency in LSD1 prevents the morphological changes and loss of 
endothelial markers associated with the EHT. Accordingly, we observed that GFI1 
and GFI1B directly bind to the regulatory regions of a large set of genes whose 
expression is maintained upon LSD1 inhibition. This set of genes is closely 
associated with cardiovascular development, as well as maintenance and 
remodelling of blood vessels.  Altogether, our results demonstrate that, in the AGM, 
the sequential expression of GFI1 proteins orchestrate the generation of HSCs by 
recruiting the CoREST complex to silence the endothelial programme. 
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RESULTS 
 
GFI1+/GFI1B- and GFI1+/GFI1B+ cells mark distinct populations within the AGM  
To determine the specific expression and potential functions of GFI1 and 
GFI1B in the emergence of HSCs, we first analysed the spatiotemporal expression 
pattern of GFI1 and GFI1B in the AGM. For this, a Gfi1:H2B-Tomato mouse reporter 
line (referred to as Gfi1tomato hereafter) was generated, validated (Supplementary Fig. 
1a) and crossed with the Gfi1b+/GFP knock-in line29. The expression of both Gfi1 and 
Gfi1b was investigated in double transgenic embryos by fluorescence activated cell 
sorting (FACS) and immunohistochemistry (IHC). At E9.5, when the dorsal aorta is 
developing within the para-aortic splanchno-pleura (P-Sp) region, Gfi1 expression 
was not detected by IHC in sections of the dual reporter embryos. Gfi1b expression 
was restricted to circulating cells likely representing primitive erythroid cells (Fig. 
1ai). 
 At E10.5, GFI1+/GFI1B- cells were found either embedded within the 
endothelium (CD31 or VE-cadherin/CDH5) (arrowheads, Fig. 1aii, Supplementary 
Fig. 1b), and/or at the base of IAHCs (arrows Fig. 1aii).  Some GFI1+ cells in IAHCs 
were also positive for GFI1B (Fig. 1aii). We next analysed the expression of Gfi1 and 
Gfi1b in the context of previously characterized markers of HE and IAHC in the 
AGM: RUNX1, c-KIT, CD41 and CD45. Staining for ȕ-Galactosidase on Runx1:nls-
LacZ/Gfi1GFP/+ E10.5 AGMs showed that Gfi1 expression was restricted to a subset 
of RUNX1+ cells within the endothelial layer (white arrows, Fig. 1b) and did not 
extend to the sub-aortic mesenchyme and endothelium (yellow arrows and 
arrowheads, Fig. 1b). Previous studies have shown that CDH5+ cells in the vDA 
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generate IAHCs that express the blood markers c-KIT and CD41 before acquiring 
CD45. These CDH5+/CD41+ and CDH5+/CD45+ intermediates represent pre-HSCs 
that mature into directly transplantable HSCs30-32. We observed that GFI1+ cells in 
the clusters co-stained for c-KIT (arrow, Fig. 1aiii), CD41 (arrow, Fig. 1aiv) and CD45 
(arrow, Fig. 1av) at E10.5. Similarly at E11.5, GFI1+GFI1B- and GFI1+GFI1B+ cells 
were still closely associated with endothelial lining and IAHCs at E11.5 (Fig. 2a).  
In agreement with the IHC data, only a very low frequency of GFI1+/GFI1B- or 
GFI1+/GFI1B+ cells were found by FACS in E10.5 and E11.5 AGMs (Fig. 2b). A large 
fraction of GFI1+/GFI1B- cells were in the CDH5+/CD45- endothelial subset or in the 
CDH5+/CD45+ double positive cell population (Fig. 2c). In contrast, GFI1+/GFI1B+
cells were mostly associated with the more mature CDH5+/CD45+ or CDH5-/CD45+
populations (Fig. 2c). Within the CDH5+ endothelial compartment, the frequency of 
GFI1+/GFI1B- was similar at E10.5 and E11.5, whereas GFI1+/GFI1B+ tended to 
increase (Supplementary Fig. 1c). Within this compartment, we also found a small 
population of cells that only expressed Gfi1b at E11.5 (Supplementary Fig.1d). 
Finally, in order to visualise the acquisition of Gfi1b expression by GFI1+ cells, we 
performed in vitro culture of FACS sorted CDH5+/GFI1+/GFI1B- cells and observed 
the emergence of GFI1B expressing cells (Supplementary Fig. 2). Similarly, time-
lapse imaging of Gfi1tomatoGfi1bgfp embryonic sections showed the acquisition of 
Gfi1b expression by CDH5+/GFI1+/GFI1B- cells (Fig. 2d, Supplementary movie1). 
Overall, these data revealed a dynamic and distinct expression pattern for
Gfi1 and Gfi1b. Gfi1 expression is initiated at E10.5 in RUNX1+ endothelial cells 
within the vDA and is sustained in the first emerging cells within the IAHCs, 
suggesting that Gfi1 expression marks HE undergoing the transition to 
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haematopoiesis. Gfi1b expressing cells, in contrast, are mainly localized in IAHCs as 
c-KIT+ cells and coincide with further commitment to CD41 and CD45 expression.  
 
GFI1+/GFI1B- cells mark HE while HSC activity is mostly associated with 
GFI1+/GFI1B+ expression 
To demonstrate that the endothelial GFI1+/GFI1B- cells correspond to HE that 
subsequently become GFI1+/GFI1B+ blood precursors, we analysed the expression 
of a set of 70 endothelial and haematopoietic genes in single cells of the different 
CDH5+ populations defined by Gfi1 and Gfi1b expression. These included endothelial 
CDH5+ cells, the CDH5+ cells expressing Gfi1 found in the endothelial lining 
(CDH5+/GFI1+/GFI1B-/c-KIT-), or emerging in the lumen (CDH5+/GFI1+/GFI1B-/c-
KIT+), the CDH5+/GFI1+/GFI1B+ cells present in the clusters and the rare population 
of CDH5+/GFI1-/GFI1B+ cells (Fig. 3a and Supplementary Fig. 3). Consistent with a 
developmental continuum between the three GFI1+ populations, principal component 
analyses indicated that CDH5+/GFI1+/GFI1B-/c-KIT- and CDH5+/GFI1+/GFI1B+ cells 
formed separate clusters but were linked by the CDH5/GFI1+/GFI1B-/c-KIT+
population (Fig. 3b). In contrast, endothelial CDH5+ or CDH5+/GFI1-/GFI1B+ cells 
clustered as separate entities with the latter displaying an expression profile 
consistent with megakaryocytes. Gfi1 expression closely co-coincided with the 
expression of endothelial genes (Dll4, Procr, Kdr, Egfl7, Notch1) whereas the 
expression of Gfi1b was linked to haematopoietic genes such as c-kit, Itga2b, CD45,
Mpo and c-myb (Fig. 3b). Together, these analyses suggest that 
CDH5+/GFI1+GFI1B-/c-KIT-, CDH5+/GFI1+/GFI1B-/c-KIT+ and CDH5+/GFI1+/GFI1B+
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are distinct but sequentially related cell populations corresponding to haemogenic 
endothelium, cells undergoing EHT and emerging haematopoietic cells, respectively. 
By definition, HE cells require a further maturation step to generate 
haematopoietic progenitors. To functionally evaluate the HE potential of the GFI1+
fraction, we isolated CDH5+/GFI1- and CDH5+/GFI1+ cells from E10.5 AGM while 
excluding blood precursors (CD41+ and/or CD45+). Both populations were plated into 
haematopoietic assay, either directly, or following a 4-day maturation step of co-
culture with OP9 cells. Direct re-plating into haematopoietic assay yielded very few 
colonies (Fig. 3d) in contrast to control sorted GFI1+ and/or GFI1B+ cells containing 
CD41+ and CD45+ cells (Supplementary Fig. 4a). Following maturation, the 
CDH5+/GFI1-/CD41-/CD45- fraction did not gain any haematopoietic potential, while 
the CDH5+/GFI1+/CD41-/CD45- cells generated haematopoietic colonies at a high 
frequency, indicating that at E10.5, HE cells were present within the CDH5+/GFI1+
population (Fig. 3d). 
Finally, we tested whether GFI1+ cells in the vDA contain HSCs.  Single cell 
suspension of Gfi1tomato/+ E11.5 AGMs were stained for CDH5 and separated into 
CDH5+/GFI1+ (that are either expressing Gfi1b or not) and CDH5+/GFI1- cells. Both 
fractions were transplanted into lethally irradiated mice. Long-term primary and 
secondary contributions were mainly detected in recipients transplanted with the 
CDH5+/GFI1+ fraction (Fig. 3ei, Fig. Supplementary Fig. 4b and 4c), indicating that 
HSC activity is restricted to the CDH5+/GFI1+ population at E11.5. We further 
separated the CDH5+/GFI1+ cell population into CDH5+/GFI1+/GFI1B- and 
CDH5/GFI1+/GFI1B+ cells in order to test if there were significant differences 
between these two populations. Consistent with the less mature state of the 
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CDH5+/GFI1+/GFI1B- cells, the repopulation potential of this fraction was lower than 
that of CDH5+/GFI1+/GFI1B+ cells (Fig 3eii). 
 
GFI1 and GFI1B are required for EHT in the AGM 
In order to investigate if GFI1 proteins have a functional importance in HSC 
emergence, we examined the presence of IAHC in E10.5 embryos. IAHC were 
readily observed in control het/het and knock-out embryos for either GFI1 or GFI1B 
(Fig. 4ai-iii and Supplementary Fig. 5a). In contrast, no c-KIT+ IAHCs were found in 
the double Gfi1s ko (Gfi1GFP/GFP/Gfi1bGFP/GFP) AGMs (Fig. 4aiv). Instead, we detected 
GFP+ cells, which were fully embedded within the lining of the vDA, suggesting a 
critical impairment in the EHT and IAHC generation. The presence of clusters in Gfi1
deficient embryos might be explained by the upregulation of Gfi1b that could result in 
a functional compensation for the loss of GFI1.  Indeed it has been previously 
demonstrated that GFI1B could functionally replace and rescue the haematopoietic 
defects observed in Gfi1 deficient animals28,33. Accordingly, we observed the 
appearance of Gfi1b transcripts in the endothelial lining of the dorsal aorta of Gfi1 
deficient embryos by in situ staining (Supplementary Fig. 5b).  By q-PCR, we also 
detected an upregulation of Gfi1b expression in the whole AGM lysate and more 
specifically in HE cells (CDH5+/GFP+/c-KIT-) of Gfi1 deficient embryos 
(Gfi1ko/Gfi1bhet)( Supplementary Fig. 5c). Altogether, these data suggest that GFI1 is 
critical for the initiation of the EHT, but that its absence can be compensated by 
induction of Gfi1b expression. 
Finally, to test whether Gfi1ko/Gfi1bko AGM cells possessed any 
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haematopoietic potential, we plated single cell suspensions of Gfi1ko/Gfi1bko AGM in 
haematopoietic assays either directly, or after a maturation step on OP9 cells (Fig. 
4b and 4c). None of the conditions led to haematopoietic colony formation, indicating 
an absolute requirement for GFI1 and GFI1B in the generation, and/or the 
subsequent maturation, of blood precursors in the AGM. 
 
LSD1 is essential for the EHT 
Both GFI1 and GFI1B have been shown to epigenetically repress transcription 
in MEL (murine erythroleukemia) cells by recruiting the chromatin regulatory 
CoREST complex34. The CoREST complex includes the histone demethylase LSD1 
(KDM1A) and the histone deacetylases, HDAC1 and HDAC2. Upon recruitment to 
target sites, HDACs and LSD1 remove the activating acetylation and methylation 
marks from histones within their proximity34. Stable repression of the target loci is 
then further induced by the recruitment of G9 or SUV39H1, and subsequent 
methylation of repressive sites.  
To investigate if the EHT is regulated by a similar epigenetic mechanism, we 
examined the consequences of pharmacological LSD1 inactivation35 on blood 
emergence during the in vitro differentiation of ES cells. In this system, FLK1+
mesodermal haemangioblasts plated in methylcellulose, form tight HE cores from 
which round haematopoietic cells emerge to produce blast colonies11,36. We first 
tested the LSD1 inhibitor in this blast colony assay and observed that increasing 
amounts of the inhibitor dramatically decreased the number of blast colonies. In 
parallel, we detected a directly correlated increase in the number of cores, 
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suggesting that the LSD1 inhibition blocks the emergence of round blood cells from 
HE cores (Fig. 5a). We next assessed the impact of LSD1 inhibition in monolayer 
cultures by time-lapse imaging and FACS. In these cultures, HE cells aggregate as 
tight and adherent clusters that are characterised by the co-expression of endothelial 
(CDH5 and TIE2/TEK) and haematopoietic markers (c-KIT and CD41). These HE 
clusters then generate free-floating haematopoietic cells concomitantly with 
progressive loss of endothelial markers9. We observed that control cells transited 
through a HE stage and generated round blood cells (Supplementary movie 2). 
Strikingly, cultures treated with the LSD1 inhibitor generated HE clusters, but did not 
progress to produce free-floating blood cells (Supplementary movie 3). FACS 
analysis of the control cultures confirmed the presence of HE cells (CDH5+/CD41+ or 
TIE2+/CD41+) and of the subsequent CD41+ single positive blood cells (Fig. 5b). In 
contrast, in the presence of the inhibitor, very few CD41+ single positive blood cells 
were detected, suggesting a block in EHT.  We confirmed this striking phenotype in 
ES cells carrying floxed Lsd1 alleles37. Upon induction of deletion, we observed a 
similar defect in the generation of round blood cells (Supplementary movie 4 and 5, 
and Supplementary Fig. 6a). Finally, consistent with previous reports38,39, we 
observed a decrease in cell proliferation and an increase in apoptosis upon Lsd1
deletion during in vitro differentiation (Supplementary Fig. 6b and 6c).  
To correlate this observation with the activity of GFI1 proteins, we assessed 
the in vitro phenotype resulting from the combined loss of Gfi1 and Gfi1b.  As 
observed for LSD1 deficiency, differentiating Gfi1ko/Gfi1bko ES cells formed HE 
clusters, but the emergence of round haematopoietic cells (Fig. 5c), as well as the 
down-regulation of CDH5 and TIE2 were not observed (Fig. 5d). To investigate if 
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LSD1 activity was also required in the AGM for the generation of blood cells, we 
analysed Lsd1 expression and performed ex-vivo LSD1 inhibition in E9.5 P-Sp 
explants and E10.5 embryonic sections of Gfi1tomato/+/Gfi1bGFP/+ embryos. We 
observed that Lsd1 is ubiquitously expressed in the mouse embryo, consistent with 
previous report37 (Supplementary Fig. 7a). Following culture of control E9.5 P-Sp 
explants, GFP+ (Gfi1b expressing) cells were found to be negative for the endothelial 
markers CD31 or CDH5 by FACS and were detected as clusters of cells by confocal 
microscopy (Fig. 5e, Supplementary movie 6). In contrast, upon LSD1 inhibition, part 
of GFI1B+ cells were still CDH5+ (Fig. 5e). In addition, some Gfi1b expressing cells 
were still found embedded within the CD31+ endothelial lining of the vDA 
(Supplementary movie 7) but expressed the haematopoietic marker CD45 (Fig. 5eii 
and Supplementary Fig. 7b). Similarly, in culture of E10.5 sections treated with the 
LSD1 inhibitor, Gfi1 and Gfi1b expressing cells remained embedded in the 
endothelial lining of the vDA (Fig. 5f and Supplementary Fig. 7c). Altogether, these 
results indicate the critical requirement of LSD1 for the emergence of blood cells, 
both in differentiating ES cells and in the AGM.  
 
GFI1 and GFI1B shut down the HE programme by recruiting LSD1 to target 
genes 
 In order to identify the genome-wide molecular changes induced by GFI1 and 
GFI1B through the recruitment of LSD1 during EHT, we compared global gene 
expression profiles of LSD1-inhibited ES-derived HE cells (CDH5+/CD41+) and the 
corresponding CD41 compartment of control cells (CDH5+/CD41+ HE and CD41+
haematopoietic cells). We found 244 protein-coding transcripts present at higher, 
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and 165 at lower, levels in LSD1-inhibited cells (Fig. 6a). Transcripts with higher 
levels in LSD1-inhibited cells were enriched for genes implicated in cardiovascular 
system development, whereas transcripts with lower levels of expression were 
associated with haematological system development/function and cell morphology 
(Fig. 6b). In parallel, we also mapped GFI1 and GFI1B binding sites in ES-derived 
HE cells using the DamID (DNA adenine methyltransferase Identification) 
strategy40,41 (Fig. 6c, Supplementary Fig. 7d). Consistent with their potential function 
in HE, the genes bound by GFI1 and/or GFI1B were highly enriched for transcripts 
involved in integrin, actin cytoskeleton, and gap junction signalling (Fig. 6d); 
pathways that need to be modulated for EHT. Next, we overlapped the lists of genes 
bound by GFI1 and/or GFI1B with the list of genes expressed at higher levels when 
LSD1 activity is blocked. The resulting list of 78 candidate genes (Fig. 7a) contained 
genes with well-established roles in stem cells (Lgr5, Lin28A, Sall1), as well as in 
cardiovascular development, blood vessels maintenance and remodelling (Egfl7, 
Nos3, Pcdh12, Ptprb, Sox7, Cdh5, Esam, Hey2, Hand2, ID1, ID3). Accordingly, this 
list was significantly enriched for genes involved in development and, in particular, in 
cardio-vascular system development (Fig. 7b). Interestingly, 33 out of the 78 genes 
have been previously shown to be bound by RUNX1 in ChIP-seq experiments during 
EHT42 (Fig. 7c and genes highlighted in red in Fig. 7a). In silico analysis also 
indicated a frequent occurrence of RBPJ binding motifs within, or close to the GFI1 
and GFI1B peaks (Fig. 7d and genes indicated by an asterisk in Fig. 7a), suggesting 
that both RUNX1 and Notch signalling could additionally regulate the transcription of 
these genes. Finally, the S1P signalling pathway, implicated in vascular 
permeability43, was found to be significantly associated with genes present in this list 
(Fig. 7b, bottom panel). Altogether, our molecular data strongly suggests that during 
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EHT, GFI1 and GFI1B bind to genes associated with the global maintenance of 
endothelial identity, and epigenetically silences this programme through the 
recruitment of the CoREST complex to orchestrate the generation of HSCs and 
blood progenitors (Fig. 7e). 
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DISCUSSION 
 
 Recent studies have conclusively demonstrated the existence of HE cells that 
have the unique ability to give rise to HSCs and blood precursors. However, the 
precise nature of this transient and rare subpopulation of endothelial cells, and how 
they generate different types of blood cells via EHT, remains poorly understood.  
In this study, we revealed an unrecognized requirement for the two 
transcriptional repressors GFI1 and GFI1B for HSC emergence in the AGM. Indeed, 
we did not detect any IAHCs or any haematopoietic potential in E10.5 Gfi1ko/Gfi1bko
AGMs, even following further maturation, indicating an absolute requirement for 
GFI1 and GFI1B for the commitment and generation of haematopoietic cells. 
Interestingly this developmental block is not observed in Gfi1 single KO suggesting 
that the critical function of GFI1 in HE cells could be rescued by the compensatory 
expression of Gfi1b that we observed in these cells. In the double KO embryos, 
discrete GFP+ cells were observed embedded within the endothelium of the vDA, 
indicating that HE cells are specified in the absence of GFI1 and GFI1B proteins, but 
are unable to progress through EHT. This is reminiscent of the situation in the yolk 
sac where the double KO GFP+ cells remain clustered together and are not 
disseminated in the vasculature28. In contrast, the absence of blood potential in 
Gfi1ko/Gfi1bko AGMs is distinct from the situation in the yolk sac where GFP+ cells 
were shown to display haematopoietic potential when dissociated and replated28.
These results suggest differences in the molecular regulation during the generation 
of blood cells in the yolk sac and in the AGM. This could also reflect the existence of 
different types of HE at these two sites, as previously suggested44. Interestingly, this 
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dichotomy mirrors the different requirements for Notch signalling which is 
dispensable for yolk sac haematopoiesis but essential for AGM haematopoiesis45-48.
Detailed analysis of the EHT has so far been challenging given the limited 
number of genetic markers specifically defining HE. Our results suggest that Gfi1 
expression identifies the specific subset of cells in the endothelial lining that are 
actively undergoing the transition to the haematopoietic fate. As such, GFI1
delineates a more refined cell population than previously described markers such as 
the endothelial markers SOX1749 and SOX750, that are widely expressed in 
endothelial cells, or the haematopoietic marker SCA-151 or RUNX120,52 that are 
extensively expressed in other AGM cell populations.  
We also revealed here, that LSD1, a member of the CoREST repressive 
complex, is critical for the EHT process. Lsd1 deficiency phenocopies the 
developmental block observed in Gfi1ko/Gfi1bko, strongly suggesting that the 
repressive function of the Gfi1s during EHT is mediated by the CoREST complex. 
Our molecular analysis identified a specific set of 78 genes that are bound and 
repressed by GFI1 and GFI1B during EHT. This list not only contains genes, that 
have not been previously identified as GFI or GFI1B targets53,54, but also some 
genes that have known, or suspected, functions in stem cell and endothelial cells. 
This list also harbours a wealth of new candidates potentially implicated in the EHT. 
In addition, a large proportion of these genes has been shown to be bound by 
RUNX142 and contains RBPJ binding motif suggesting that GFI1 repression, RUNX1 
binding and Notch signalling overlap and cooperate to orchestrate the EHT process 
in the AGM.  
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Altogether, our study provides mechanistic insights and valuable novel 
candidates and leads for future studies of the molecular programme governing HE 
specification and the generation of blood cells and HSCs in the AGM. Deciphering 
the regulatory pathways that specifically control this EHT process is essential for  
precisely recapitulating this programme during ES cell differentiation55-58 or during 
reprogramming59-61 to ultimately generate HSCs in vitro. 
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Figure Legends 
 
Figure 1 GFI1 and GFI1B define distinct cell populations in the E10.5 AGM 
 (a i-v) IHC on E9.5 and E10.5 Gfi1tomato/ Gfi1bGFP embryos for CD31 and CDH5 
(both red), GFI1 (cyan), GFI1B (green) and c-KIT, CD41 and CD45 (yellow). (i) E 9.5 
P-Sp. (ii) GFI1+/GFI1B- cells (arrowhead) and GFI1+/GFI1B+ cells (arrow) are 
indicated. (iii) GFI1 and c-KIT are co-expressed (white arrow). (iv) CD41 and GFI1 
are co-expressed (white arrow). (v) CD45, GFI1 and GFI1B co-expression (white 
arrow). (b) Staining for Runx1 (beta-Galactosidase) (yellow), CD31 (red) and GFI1 
(cyan). Co-expression of CD31, GFI1 and RUNX1 (white arrow), CD31 and RUNX1 
(yellow arrow) or only RUNX1 expression (yellow arrowhead) are indicated. 
Representative images of AGM sections derived from more than 5 embryos from 
different litters are shown. Scale bars =10 um.  
 
Figure 2 GFI1 marks haemogenic endothelial cells in the E10.5 AGM
(ai and aii) IHC for CDH5 (red), GFI1 (cyan), GFI1B (green) and CD45 (yellow) at 
E11.5. (i) GFI1+/GFI1B- (arrowhead) and GFI1+/GFI1B+ cells (arrow) are indicated. 
(ii) GFI1+/GFI1B+ cells co-expressing CD45 (arrow) are indicated (Representative 
images of AGM sections derived from more than 3 embryos from different litters are 
shown). (b) FACS analysis of Gfi1 (TOMATO) and Gfi1b (GFP) expression in E10.5 
and  E11.5 AGM (Representative FACS data from more than 2 different litters are 
shown). (c) FACS analysis of CDH5 and CD45 expression by GFI1+/GFI1B- and 
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GFI1+/GFI1B+ cells in E10.5 and E11.5 AGMs (Representative FACS data from 
more than 2 different litters are shown). (d) Images from time-lapses performed on 
Gfi1tomatoGfi1bgfp E10.5 sections stained with CD31 (n= 3 independent experiments 
with AGMs from 2 or more embryos, one representative sequence of imaging is 
shown). Scale bar = 10 μm.
 
Figure 3 GFI1+ cells acquire GFI1B expression and habour HSC activity 
(a) Schematic representation of the sorting strategy for the single cell PCRs. (b)
Principal component analysis for cells and genes analysed (left panel). Prinicipal 
component analysis for endothelial and haematopoietic genes expressed by 
CDH5+/GFI1+/c-KIT- and CDH5+/GFI1+/GFI1B+ cells (right panel). (c) Violin plots of 
single cell PCR data for the indicated genes (data is derived from one single 
Fluidigm single cell PCR run performed with n= 96 AGM cells from 3 different litters). 
(d) Haemogenic potential of E10.5 CDH5+/GFI1+/CD41-/CD45- and CDH5+/GFI1-
/CD41-/CD45- cells. The CDH5+/GFI1+/CD41-/CD45- and CDH5+/GFI1-/CD41-/CD45-
populations were either directly re-plated or replated after a co-aggregation step with 
OP-9 cells for 4 days (2 independent experiments were performed with AGMs from  
2 and 9 embryos. Data from one representative experiment is shown; the source 
data for the second experiment can be found in Statistics source data ). (e) (i) Long 
term repopulation potential of E11.5 CDH5+/GFI1+ and CDH5+/GFI1- cells from 
Gfi1tomato AGMs. Donor contributions to the LSK compartment at 17 weeks after 
transplantation are shown (one independent experiment with AGM cells sorted from 
one litter). (ii) E11.5 Gfi1tomatoGfi1bgfp AGMs were dissociated and the 
CDH5+/GFI1+/GFI1B- and CDH5+/GFI1+/GFI1B+ cells were injected intravenously 
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into irradiated NSG mice. Donor contributions to the LSK compartment at 16 weeks 
after transplantation are shown (one independent experiment with AGM cells sorted 
from one litter). 
 
Figure 4 GFI1 and GFI1B are essential for intra-aortic Cluster formation 
(a) IHC on Gfi1het/Gfi1bhet (Gfi1GFP/+/Gfi1bGFP/+), Gfi1KO/Gfi1bhet 
(Gfi1GFP/GFP/Gfi1bGFP/+), Gfi1het/Gfi1bKO (Gfi1GFP/+/Gfi1bGFP/GFP) and Gfi1KO/Gfi1bKO
(Gfi1GFP/GFP/Gfi1bGFP/GFP) E10.5 AGMs for CD31 (red), GFI1 and GFI1B (green) and 
c-KIT (yellow) (Representative images of AGM sections derived from more than 4 
embryos from different litters are shown). (b and c) Haematopoietic potential of 
Gfi1het/Gfi1bhet and Gfi1ko/Gfi1bko AGMs. Cells were re-plated either directly (b) or 
after a co-aggregation step with OP-9 cells for 4 days (one independent experiment 
with AGM cells sorted from one litter) (c) into haematopoietic colony assays (one 
independent experiment with AGM cells sorted from one litter). Scale bar = 10um.  
 
Figure 5 LSD1 is critical for EHT  
(a) ES-derived FLK1+ cells were either cultured with DMSO or different 
concentrations of the LSD1 inhibitor in blast assays (one representative experiment 
out of 2 independent experiments is shown, data from the second experiment can be 
found in statistical source data). (b,d) CD41+ single (black arrow), TIE-2+/CD41+ and 
CDH5+/CD41+ double positive (grey arrow) cells are indicated. (b) FACS on day 3 
monolayer cultures of ES-derived FLK1+ cells treated with DMSO or LSD1 inhibitor 
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(300nM) (Representative FACS plots of more than 6 independent experiments). (c)
Time-lapse images of monolayer cultures (Day 3) of Gfi1ko/Gfi1bko or Gfi1het/Gfi1bhet
ES-derived FLK1+ cells (Representative images of 2  independent experiments). 
Scale bar: 50um. (d) FACS on cells isolated from day 5 EBs of Gfi1ko/Gfi1bko or 
Gfi1het/Gfi1bhet (Representative FACS plots of more than 6 independent 
experiments). (e) E9.5 P-Sp Gfi1tomato/ Gfi1bGFP explant cultures treated with DMSO 
(Ctrl) or LSD1 inhibitor (300-500nM). (i) The explants were either analysed by FACS 
for the presence of GFI1B+ cells in the CDH5+ endothelial compartment 
(Representative data of more than 3 independent experiments) or (ii) by imaging to 
generate 3D reconstruction of E9.5 AGM explants cultured with DMSO (DMSO ctrl) 
or 500nM of the LSD1 inhibitor (LSD1 inhib) (Representative data of 3  independent 
experiments). IHC for CD31 (red), GFI1 (cyan) and GFI1B (green) was performed 
prior to imaging. (iii) Imaging of E10.5 Gfi1tomato/ Gfi1bGFP AGM sections after 
overnight ex vivo culture with DMSO (DMSO ctrl) or 500nM of the LSD1 inhibitor 
(LSD1 inhib) (Representative data of 3 independent experiments).  Scale bars: 
20μm.  
 
Figure 6 Molecular programme governed by LSD1 and GFI1/1B 
 (a) Heat map of differentially expressed genes between ES-derived CD41+ cells Day 
2 liquid blast culture in presence of LSD1 inhibitor (300nM) or DMSO. (b) Molecular 
function of the genes expressed at higher, and lower levels, in the LSD1 inhibited 
cells compared to control cells. (c) Schematic representation of the DamID 
technique. (d) GO terms of genes bound by GFI1 and GFI1B in day 2 Liquid Blast 
derived HE cells. 
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Figure 7 Identification of genes repressed by GFI1 and GF1B in HE 
(a) Overlap of genes bound by Gfi1 and Gfi1b and expressed at higher levels of 
transcription upon LSD1 inhibition. Genes previously shown to harbour RUNX1 
ChIP-seq peaks are indicated in red and genes with RBPJ binding motifs within 
100bp of GFI1 or GFI1B peaks are indicated by an asterisk. (b) Functional 
classification and pathway enrichment analysis for the 78 candidate genes. (c) Pie 
chart representing the number of genes with/out RUNX1 Chip-seq binding peaks. (d)
RBPJ binding motif identified by HOMER in 100bp proximity of GFI1 and/or GFI1B 
peaks. (e) Model of the expression patterns and function of GFI1 and GFI1B during 
HE specification and EHT in the AGM.  
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Figure legends for Supplementary Figures 1- 7 
 
Supplementary Figure 1 Gfi1tomato mouse line  
(a) FACS analysis of Gfi1tomato and Gfi1GFP/+ bone marrow cells after staining for 
lymphoid (CD4/CD8) and myeloid (GR-1/MAC-1) markers.  Bone marrow 
populations were gated into GFP- and GFP+ for Gfi1GFP/+ (top panel) and TOM- and 
TOM+ for Gfi1tomato (lower panel) fractions (representative FACS plot of one 
independent experiment). (b) IHC for CD31 (red), GFI1 (cyan) and GFI1B (green) on 
E10.5 AGM section counterstained with DAPI (representative images of 3 
independent experiments). (c) Frequencies of GFI1+/GFI1- and GFI1+/GFI1+ cells in 
the CDH5 compartment of E10.5 and E11.5 AGMs (AGMs from 11 independent 
litters, n= 6 for E10.5 and n=4 for E11.5 were analysed, p-values were determined 
by a two-tailed Student’s t-test. Source data is available in Statistics source data file). 
(d) FACS analysis of GFI1 and GFI1B cells in the CDH5 compartment of E11.5 
AGMs (representative FACS plot from one independent experiment). Scale bar = 
10um.  
 
Supplementary Figure 2 GFI1+/GFI1B- cells gain GFI1B expression in vitro  
(a) CDH5+/GFI1+/GFI1B- cells were FACS sorted from Gfi1tomatoGfi1GFP/+  E10.5 AGM 
and cultured on OP-9 stromal cells. Images at day 2 and 7 of in vitro cultures 
(representative images of n=4 independent experiments). (b) Day 7 cultures were 
analysed by FACS and indicated gates were used for sorting (c) The initial sorted 
E10.5 CDH5+/GFI1+/GFI1B- AGM cells and the different cell populations isolated 
after 7 days of their cultures (GFI1+/GFI1B-, GFI1+/GFI1B+, GFI1-/GFI1B+) were 
analysed for Gfi1b expression level by q-PCR (representative data from one 
experiment).  
 
Supplementary Figure 3 Heatmap of all cells and genes analysed by single cell 
PCR  
Heat map depicting the clustering all the single cells and genes analysed.  
 
Supplementary Figure 4 E11.5 CDH5+/GFI1+ cells contribution to recipients  
 (a) GFI1 and GFI1B expression mark all hematopoietic cells in the E10.5 AGM (i) 
schematic representation of the experimental design (ii and iii) E10.5 AGM cells 
were FACS sorted and re-plated into haematopoietic assay either before (one 
independent experiment with embryos from one litter) (ii) or after (one independent 
experiment with embryos from one litter) (iii) co-culture step with OP-9. Colonies 
were scored 9-11 days later. (b) FACS analysis of recipients transplanted with either 
CDH5+/GFI1+ or CDH5+/GFI1- E11.5 AGM cells (CD45.1/CD45.2 double positives) at 
17 weeks after transplantation. Bone marrow LSK compartments of recipients 
(CD45.1) were analysed for CD45.1 and CD45.2 (representative FACS plots of one 
independent experiment).  (c) Donor contribution to haematopoietic lineages 
determined by sub-gating on CD45.1/CD45.2 double positive population in the 
recipient. Donor contribution to T cells (CD4/CD8) in the spleen and thymus, B cells 
(IgM/B220), myeloid cells (GR-1/MAC-1) and erythroid cells (CD71/TER119) in 
different haematopoietic organs are shown (representative FACS plots of one 
independent experiment). 
 
Supplementary Figure 5 GFI1 or GFI1B single knock out embryos can generate 
IAHC 
 (a) IHC on E10.5 GFI1KOGFI1B+/+ and GFI1+/+GFI1BKO AGM section for CD31, GFP 
and c-KIT (counterstained with DAPI) (representative images of one independent 
experiment with embryos form different litters). (b) In situ hybridisation for Gfi1b (red 
dots) and IHC for CD31 (brown) on GFI1GFP/+GFI1BGFP/+ and GFI1KOGFI1BGFP/+ 
E10.5 embryo sections. (c) qPCRs on E10.5 AGM cells. (i) qPCR for Gfi1 and Gfi1b 
expression in AGM cell lysate of GFI1GFP/+GFI1BGFP/+ (het/het), 
GFI1GFP/GFPGFI1BGFP/+ (KO/het) and GFI1GFP/+GFI1BGFP/GFP (het/KO) embryos 
(representative data from one independent experiment with embryos from the same 
litter). (ii) PCR for Gfi1 and Gfi1b on sorted CDH5+/GFP+/c-KIT- HE cells of 
GFI1GFP/+GFI1BGFP/+ (het/het) and GFI1GFP/GFPGFI1BGFP/+ (KO/het) embryos (one 
independent experiment with embryos from the same litter). Scale bar=10um 
 
Supplementary Figure 6 Conditional Lsd1 knock-out recapitulates LSD1 
inhibition phenotype and leads to decrease in proliferation and apoptosis 
 (a) FLK1+ cells from the conditional Lsd1∆/lox line were isolated from day 3 EBs and 
cultured as monolayer. FACS analysis on 3 consecutive days with staining for TIE-2, 
CDH5 and CD41 are shown. Lsd1∆/lox FLK1+ cells were either cultured with control 
ETOH or with 1uM of 4OHT (in ETOH) to induce the activity of Cre-ERT2 and 
generate Lsd1∆/∆ (representative FACS plots of 3 independent experiments) (b) EdU 
assay on Day 3 control (Lsd1∆/lox) or Lsd1 deleted (Lsd1 ∆/∆) Blast cultures 
(Representative FACS plots of one independent experiment). (c) Annexin5/7-AAD 
staining on Day 3 control (Lsd1∆/lox) or Lsd1 deleted (Lsd1∆/∆) Li-Blast cultures. 
Additionally, the cultures were stained with CD41 to differentiate between HE and 
non-HE cells.  
 
Supplementary Figure 7 LSD1 is ubiquitously expressed and its inhibition 
leads to loss of EHT in E10.5 AGM.  
(a) IHC for CD31, tomato and LSD1 on E10.5 AGM sections of Gfi1tomato embryos 
(counterstained with DAPI). (b) IHC for CDH5, GFI1 and CD45 on E9.5 P-Sp 
explants. (c) Single channel control images from live imagining of E10.5 
Gfi1tomatoGfi1GFP/+ AGM slices wither treated with DMSO (ctrl) or 500nM of the LSD1 
inhibitor. (di-iii) Screen shots of the Oit-3, Gata-2 and Hey-2 locus from the UCSC 
browser showing examples of GFI1:DAM (Cyan) and GFI1B:DAM (green) binding 
enrichment after sequencing.  Region of interest is marked with a black box and 
specific peaks detected are highlighted with black bars below.  
 
  
Supplementary video 1 
Time lapse of culture of sections of E10.5 Gfi1Tomato/Gfi1bGFP AGMs. 
 
Supplementary video 2 
Time-lapse imaging of FLK1+ cells blast monolayer cultures treated with DMSO 
(DMSO Ctrl).  
 
 Supplementary video 3  
Time-lapse imaging of FLK1+ cells blast monolayer cultures treated with 300nM of 
the LSD1 inhibitor (LSD1 inhib). 
 
Supplementary video 4  
3D re-construction of z-stacks (4.2um) of E9.5 P-Sp explants (2 days cultures) 
treated with DMSO and stained for CD31 (red), GFI1 (cyan) and GFI1B (green).  
 
Supplementary video 5  
3D re-construction of z-stacks (4.1um) of E9.5 P-Sp explants (2 days cultures) 
treated with the LSD1 inhibitor (300nM) and stained for CD31 (red), GFI1 (cyan) and 
GFI1B (green). 
 
Supplementary movie 6  
Time-lapse imaging of FLK1+ cells from the cLsd1 ES line in Liquid Blast culture 
treated with EtOH (Lsd1∆/lox). 
 
Supplementary movie 7  
Time-lapse imaging of FLK1+ cells from the cLsd1 ES line in Liquid Blast culture 
treated with 4-OHT (Lsd1∆/∆). 
 
Supplementary table 1 
List of primary and secondary antibodies and their dilution used in this study  
 
Supplementary table 2 
Raw data file from the single cell q-PCR Biomark platform showing the Ct values for 
each cell and gene analyzed 
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